Skip to content

SLN - Silence Therapeutics plc - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchS

Silence Therapeutics PLC

SLN · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

S

SLNSilence Therapeutics PLC

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $17.58
52-wk low: $4.19
Prev close: $10.36
Mkt cap: $845.9M
Beta: 1.41
P/S: 1375.5x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$41.7M

CI
Citadel
Ken Griffin · Q2 2026 13F
$14.6M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 18.8% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $846M

Valuation

P/S1375.47
P/B22.80

Quality

Operating margin-10476.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: SLN
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $845.92M
Beta: 1.41

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

22.8x

Profit margin

+0.0%

Op margin

-10476.0%

ROE

-90.4%

$10.0M

position

BA

Balyasny

Dmitry Balyasny · Q2 2026 13F

$6.7M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for SLN

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.26+18.8%

-$0.32 expected

Next report

What the street expects next

-90.4%

ROA-29.6%

Growth

Beta1.41